The remission rates of type 2 diabetes after laparoscopic adjustable gastric banding are influenced by the duration of disease, according to interim results from the APEX study…. 

Drugs aimed at halting the molecular destruction of beta cells are likely the next step in the quest to stop the progression of autoimmune type 1 diabetes….

The dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin (Tradjenta, Boehringer Ingelheim and Lilly) is associated with significant improvements in glycated hemoglobin (HbA1c) in black patients with type 2 diabetes…. 

  Patients with diabetes experience significantly higher rates of surgical and systemic complications, higher mortality and increased length of stay during hospitalization following 11 major elective procedures….

Gastric bypass results in greater loss of lean muscle mass…. 

Almost half of nonobese adult with poorly controlled diabetes have latent autoimmune diabetes that has been misdiagnosed as type 2 diabetes….

Two years of treatment with an investigational combination of phentermine plus topiramate (Qnexa, Vivus) resulted in improved cardiometabolic risk factors, in addition to weight loss….

Are low-carb strategies OK for the kidneys of obese individuals without kidney disease?…

Steve, Andrew, and I are back from the AACE meeting in Philly and have loaded this week’s newsletter with the latest news from the meeting. We heard some great information on the prediction and prevention of type 1 diabetes, as well as the use of bypass and gastric banding to …

This week we bring you another fantastic Clinical Text to help you give the best care to your patients with diabetes. The ADA’s Diabetes Ready Reference for Nurse Practitioners is a fabulous reference for all medical professionals. If you remember, last week we had a close call in our Disaster …